Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05417763
Other study ID # CTP-01-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 28, 2022
Est. completion date December 1, 2022

Study information

Verified date December 2023
Source Insight Lifetech Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

TruePhysio pressure microcatheter is a novel device for evaluating the functional significance of coronary stenosis, and its safety and efficacy on the measurement of hyperemic index have been validated in the previous SUPREME study (NCT03541577). This study will further evaluate the safety and efficacy of the physiological indices measured by the TruePhysio pressure microcatheter, including resting and hyperemic indices, with respect to the physiological indices measured by the Pressure Wire.


Description:

This study will evaluate the safety and efficacy of the constant-resistance ratio (cRR) measured by the TruePhysio pressure microcatheter, in both binary and hybrid strategy, with respect to its own fractional flow reserve (FFR) and the FFR or resting full-cycle ratio (RFR) by the Pressure Wire. And the safety and efficacy of the FFR measured by the TruePhysio pressure microcatheter in patients with a border range of diameter stenosis also be validated with respect to the FFR by the Pressure Wire. The diagnostic accuracy of cRR by the TruePhysio pressure microcatheter system is evaluated, using FFR measured by both systems as reference; Mean bias between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire is evaluated, using FFR measured by Pressure Wire as the reference; The diagnostic accuracy of the hybrid cRR-FFR scheme by the TruePhysio pressure microcatheter is evaluated, using its own FFR as reference; The diagnostic accuracy of the hybrid RFR-FFR scheme by the Pressure Wire system is evaluated, using its own FFR as reference. The hybrid scheme for cRR-FFR (pressure microcatheter system), or RFR-FFR (pressure wire system), is defined as following: - the gray zone is defined as where the sensitivity and specificity are equal, shown as [A, B]. - if cRR or RFR of the target vessel is B, it is diagnosed as functionally negative in myocardial ischemia; - if cRR or RFR of the target vessel is between A and B (including A and B), the diagnostic criterion is superseded by that of FFR, which is: - if FFR of the target vessel is > 0.80, it is diagnosed as functionally negative in myocardial ischemia; - if FFR of the target vessel is ≤ 0.80, it is diagnosed as functionally positive in myocardial ischemia. A total of 487 patients are anticipated to be recruited from 11 centers in China.


Recruitment information / eligibility

Status Completed
Enrollment 487
Est. completion date December 1, 2022
Est. primary completion date July 16, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - At least 18 years old; - Having at least one 30-90% coronary artery stenosis by visual estimation under angiogram; - Clinically indicated to physiological assessment. Exclusion Criteria: - Unable to comprehend, or unwilling to sign the informed consent form; - Contraindicated to the procedures of invasive coronary angiography or percutaneous coronary intervention; - Clinically diagnosed with severe coronary artery vasospasm; - Other operator-discerned facts that will make enrollment or the procedure impossible to complete.

Study Design


Intervention

Device:
Randomized physiological measurements by the two systems
To measure physiological indices (FFR, cRR and RFR), either pressure microcatheter or pressure wire enters one patient's body. Whether it is the pressure microcatheter or pressure wire firstly to enter is randomized. After completion of one system's physiological assessment, the other system will follow for its physiological assessment.

Locations

Country Name City State
China Peking University Third Hospital Beijing Beijing
China First Affiliated Hospital of Chongqing Medical University Chongqing Chongqing
China Guangdong Provincial People's Hospital Guangzhou Guangdong
China Sir Run Run Shaw Hospital Hangzhou Zhejiang
China First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang
China Shandong Provincial Hospital Jinan Shandong
China Shanghai Zhongshan Hospital Shanghai Shanghai
China First Affiliated Hospital of Xinjiang Medical University Ürümqi Xinjiang
China First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang
China Xiamen Cardiovascular Hospital, Xiamen University Xiamen Fujian
China Affiliated Hospital of Zunyi Medical University Zunyi Guizhou

Sponsors (12)

Lead Sponsor Collaborator
Insight Lifetech Co., Ltd. First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Xinjiang Medical University, Guangdong Provincial People's Hospital, Peking University Third Hospital, Shandong Provincial Hospital, Shanghai Zhongshan Hospital, Sir Run Run Shaw Hospital, Xiamen Cardiovascular Hospital, Xiamen University, Zunyi Medical College

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The accuracy of cRR measured by TruePhysio pressure microcatheter in diagnosing myocardial ischemia Using FFR measured by TruePhysio pressure microcatheter as the reference. The optimal binary cutoff for cRR is determined by using Youden's index. Immediate upon completion of the procedure for the last enrolled patient
Secondary The area under the Receiver Operating Characteristic (ROC) curve (AUC) of cRR measured by the TruePhysio pressure microcatheter in diagnosing myocardial ischemia Using FFR measured by TruePhysio pressure microcatheter as the reference Immediate upon completion of the procedure for the last enrolled patient
Secondary The sensitivity, specificity, positive and negative predictive values of cRR measured by TruePhysio pressure microcatheter in diagnosing myocardial ischemia Using FFR measured by TruePhysio pressure microcatheter as the reference. The optimal binary cutoff for cRR is determined by using Youden's index. Immediate upon completion of the procedure for the last enrolled patient
Secondary The AUC of cRR measured by the TruePhysio pressure microcatheter in diagnosing myocardial ischemia Using FFR measured by Pressure Wire as the reference Immediate upon completion of the procedure for the last enrolled patient
Secondary The overall accuracy, sensitivity, specificity, positive and negative predictive values of cRR in diagnosing myocardial ischemia Using FFR measured by Pressure Wire as the reference. The optimal binary cutoff for cRR is determined by using Youden's index. Immediate upon completion of the procedure for the last enrolled patient
Secondary The AUC of RFR measured by the Pressure Wire in diagnosing myocardial ischemia Using FFR measured by Pressure Wire as the reference Immediate upon completion of the procedure for the last enrolled patient
Secondary The overall accuracy, sensitivity, specificity, positive predictive value and negative predictive value of RFR in diagnosing myocardial ischemia Using FFR measured by Pressure Wire as the reference. The binary cutoff for RFR is determined by previous study as 0.89. Immediate upon completion of the procedure for the last enrolled patient
Secondary The overall accuracy, sensitivity, specificity, positive and negative predictive values of the hybrid cRR-FFR scheme, concluded by TruePhysio pressure microcatheter, in diagnosing myocardial ischemia Using FFR measured by the TruePhysio pressure microcatheter as the reference. The gray zone is defined as where the false positive and negative ratios are equal. Immediate upon completion of the procedure for the last enrolled patient
Secondary The proportion of the subcohort, whose cRR value is in the gray zone of the hybrid cRR-FFR scheme, to the entire cohort Using FFR measured by the TruePhysio pressure microcatheter as the reference. Each enrolled patient only has one vessel to be physiologically assessed. Immediate upon completion of the procedure for the last enrolled patient
Secondary When the cRR value is out of the gray zone of the hybrid cRR-FFR scheme, the cRR-FFR hybrid scheme's accuracy in diagnosing myocardial ischemia Using FFR measured by the TruePhysio pressure microcatheter as the reference Immediate upon completion of the procedure for the last enrolled patient
Secondary The overall accuracy, sensitivity, specificity, positive and negative predictive values of the hybrid RFR-FFR scheme, concluded by Pressure Wire, in diagnosing myocardial ischemia Using FFR measured by the Pressure Wire as the reference. The gray zone is determined by previous study as [0.86, 0.93]. Immediate upon completion of the procedure for the last enrolled patient
Secondary The proportion of the subcohort, whose RFR value is in the gray zone of the hybrid RFR-FFR scheme, to the entire cohort Using FFR measured by the Pressure Wire as the reference. Each enrolled patient only has one vessel to be physiologically assessed. Immediate upon completion of the procedure for the last enrolled patient
Secondary When the RFR value is out of the gray zone of the hybrid RFR-FFR scheme, the RFR-FFR hybrid scheme's accuracy in diagnosing myocardial ischemia Using FFR measured by the Pressure Wire as the reference Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Pearson correlation between the cRR and FFR measured by TruePhysio pressure microcatheter Paired values are analyzed by Pearson correlation Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Passing-Bablok regression analysis between the cRR and FFR measured by TruePhysio pressure microcatheter Paired values are analyzed by Passing-Bablok regression Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Pearson correlation between the RFR and FFR measured by Pressure Wire Paired values are analyzed by Pearson correlation Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Passing-Bablok regression analysis between RFR and FFR measured by Pressure Wire Paired values are analyzed by Passing-Bablok regression Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Passing-Bablok regression analysis between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire Paired cRR-RFR values by the two systems are analyzed in Passing-Bablok regression Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Bland-Altman analysis between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire Paired cRR-RFR values by the two systems are analyzed in Bland-Altman analysis Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Pearson's correlation between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire Paired cRR-RFR values by the two systems are analyzed in Pearson correlation Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Pearson correlation between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire Paired FFR values by the two systems are analyzed by Pearson correlation Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Passing-Bablok regression analysis between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire Paired FFR values by the two systems are analyzed by Passing-Bablok regression Immediate upon completion of the procedure for the last enrolled patient
Secondary Mean bias between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire as assessed by Bland-Altman analysis Using FFR measured by Pressure Wire as the reference Immediate upon completion of the procedure for the last enrolled patient
Secondary Results of Bland-Altman analysis between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire among the patients with atrial fibrillation or in severe stenosis or with small vessels Using FFR measured by Pressure Wire as the reference. The severe stenosis is defined as the diameter stenosis higher than 70%, while the small vessel is defined as the reference vessel diameter smaller than 2.5 mm. Immediate upon completion of the procedure for the last enrolled patient
Secondary Rate of significant drift Drift is defined as the difference between FFR value and 1 when pressure sensor is pulled back to coronary artery ostium for verification.
Significant drift occurs when the device has a drift with absolute value > 0.03; alternatively, drift is regarded as significant when the Pd/Pa at the ostium for verification is either <0.97 or >1.03.
Significant drift is recorded per appearance, regardless whether the measurement is eventually successful or not. Its rate is calculated as:
Times of significant drift occurred in total / Times of measuring attempted in total
Immediate upon completion of the procedure for the last enrolled patient
Secondary Rate of device success Device success is defined when a device successfully crossed the lesion and completed acquisition of valid physiological values.
For any vessel, if valid cRR and FFR values by the TruePhysio pressure microcatheter are acquired, the measurement of TruePhysio pressure microcatheter is successful in the specific vessel, disregarding how many times it was attempted;
For any vessel, if valid RFR and FFR values by the Pressure Wire are acquired, the measurement of Pressure Wire is successful in the specific vessel, disregarding how many times it was attempted.
Rate of device success is calculated as:
Vessels with device success / Total vessels
Immediate upon completion of the procedure for the last enrolled patient
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Coronary De Novo Lesions N/A